Table 5.

Bivariate and multivariate analysis of graft and patient survival.

Variable	Bivariate			Multivariate
	HR [exp(β)]	95% CI	p-value*	HR [exp(β)]	95% CI	p-value*
Graft Survival
DCD	2.45	1.35–4.44	0.007	2.64	1.43–4.88	0.002
Recipient age (per 10 years)	1.25	0.97–1.62	0.09	1.35	1.04–1.75	0.02
Recipient race/ethnicity
White (reference)	1.00	NA	NA	1.00	NA	NA
African-American	2.06	0.97–4.37	0.06	2.19	0.99–4.81	0.051
Other (hispanic and asian)	0.86	0.31–2.39	0.78	0.65	0.24–1.82	0.42
Hepatocelluar carcinoma	0.62	0.36–1.07	0.08	0.60	0.30–1.22	0.16
MELD (calculated)	1.02	0.96–1.04	0.10	1.004	0.97–1.04	0.81
Patient Survival**
DCD	1.86	0.86–4.01	0.12	1.75	0.80–3.84	0.17
Recipient age (per 10 years)	1.39	1.006–1.92	0.05	1.50	1.09–2.06	0.01
Recipient race/ethnicity
White (reference)	1.00	NA	NA	1.00	NA	NA
Afrincan-American	1.15	0.41–3.24	0.79	0.99	0.34–2.87	0.99
Other (hispanic and asian)	0.41	0.10–1.72	0.23	0.43	0.10–1.78	0.24
Hepatocelluar carcinoma	0.70	0.36–1.35	0.28	0.90	0.39–2.10	0.81
MELD (calculated)***	1.03	1.00–1.06	0.05	1.03	0.99–1.07	0.10

^*In bivariate analysis, p-value <0.10 was considered significant; p<0.05 significant in multivariate model.

^**Patient survival adjusted according to same multivariate model applied to graft survival.

^***Hazard ratios reported per unit increase in MELD score.